首页> 外文期刊>Seminars in Diagnostic Pathology >A new molecular paradigm in mycosis fungoides and Sezary syndrome
【24h】

A new molecular paradigm in mycosis fungoides and Sezary syndrome

机译:一种新的分子范式在肌胞菌诱导和Sezary综合征中

获取原文
获取原文并翻译 | 示例
       

摘要

Mycosis Fungoides (MF) and Sezary Syndrome (SS) are clonal proliferations of mature T-cells manifesting as lymphoproliferative disorders in which the neoplastic cells show a strong propensity for skin-homing. While the predominant site of presentation in MF is the skin, the peripheral blood carries a significant tumor burden in Sezary Syndrome such that it resembles a "leukemic" disease. While the genetic basis of these diseases has been studied using different approaches in the previous years, recent genome-wide studies employing massively parallel sequencing techniques now offer new insights into the molecular pathogenesis of these diseases. In this chapter, we discuss the recent findings elucidating the genomic landscape of MF and SS. The pathways targeted by mutational alterations are discussed and a model for understanding the pathogenesis of these diseases is proposed. It is anticipated that prognostic stratification and therapeutic targeting based on mutational signatures will be achieved in the near future based on the improved understanding of the molecular pathogenesis of these diseases. (C) 2017 Elsevier Inc. All rights reserved.
机译:肌菌诱导(MF)和Sezary综合征(SS)是成熟T细胞的克隆增殖,表现为淋巴抑制性疾病,其中肿瘤细胞显示出强烈的皮肤宿主倾向。虽然MF中介绍的主要位点是皮肤,但外周血患有SEZARY综合征的显着肿瘤负担,使其类似于“白血病”疾病。虽然这些疾病的遗传基础已经在前几年使用不同的方法研究,但最近采用大规模平行测序技术的基因组研究现在为这些疾病的分子发病机制提供了新的见解。在本章中,我们讨论最近阐明MF和SS基因组景观的最新发现。讨论了突变改变靶向的途径,并提出了理解这些疾病发病机制的模型。预计基于改善对这些疾病的分子发病机制的改善,将在不久的将来实现基于突变签名的预后分层和治疗靶向。 (c)2017年Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号